Zentalis Pharmaceuticals (ZNTL) Tax Rate (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Tax Rate came in at 0.34% in Q1 2026, up 73.2% quarter-over-quarter from 1.27% in Q4 2025.
Zentalis Pharmaceuticals has reported Tax Rate for 8 years, with the latest figure at 0.34% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate changed N/A year-over-year to 0.34%; the trailing twelve-month figure through Mar 2026 stood at 0.45% (down 44.0% YoY), and the FY2025 full-year result was 0.32%, down 22.0% from the prior year.
- Tax Rate for Q1 2026 stood at 0.34%, up from 1.27% in the prior quarter.
- The five-year high for Tax Rate was 1.4% in Q1 2024, with the low at 1.27% in Q4 2025.
- Average Tax Rate over 5 years is 0.11%, with a median of 0.02% recorded in 2022.
- Year-over-year, Tax Rate tumbled 593 bps in 2022 and surged 158 bps in 2024.
- Tracing ZNTL's Tax Rate over 5 years: stood at 0.74% in 2022, then plunged by 70 bps to 0.22% in 2023, then soared by 95 bps to 0.43% in 2024, then plunged by 396 bps to 1.27% in 2025, then soared by 73 bps to 0.34% in 2026.
- The last three Tax Rate figures came in at 0.34% (Q1 2026), 1.27% (Q4 2025), and 0.43% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.34 |
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | -1.27 |
| Dec 31, 2025 | -1.27 |
| Dec 31, 2024 | 0.43 |
| Dec 31, 2024 | 0.43 |
| Sep 30, 2024 | 0.07 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.30 |
| Mar 31, 2024 | 1.40 |
| Mar 31, 2024 | 1.40 |
| Dec 31, 2023 | 0.22 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | -0.06 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | 0.61 |
| Jun 30, 2023 | 0.61 |
| Mar 31, 2023 | -0.18 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | 0.74 |
| Dec 31, 2022 | 0.74 |
| Sep 30, 2022 | 0.30 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.03 |
| Mar 31, 2022 | -0.06 |
| Mar 31, 2022 | -0.06 |
| Dec 31, 2021 | -0.33 |
| Dec 31, 2021 | -0.33 |
| Sep 30, 2021 | 6.23 |
| Sep 30, 2021 | 6.23 |
| Jun 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.08 |
| Mar 31, 2021 | -0.39 |
| Mar 31, 2021 | -0.39 |
| Dec 31, 2020 | -1.07 |
| Dec 31, 2020 | -1.07 |
| Sep 30, 2020 | -0.05 |
| Sep 30, 2020 | -0.05 |
| Sep 30, 2019 | -0.01 |
| Sep 30, 2019 | -0.01 |
| Jun 30, 2019 | -0.10 |
| Jun 30, 2019 | -0.10 |
| Mar 31, 2019 | -0.03 |
| Mar 31, 2019 | -0.03 |